Korean Circ J.  2011 Dec;41(12):712-717. 10.4070/kcj.2011.41.12.712.

The Economic Burden of Inflammatory Heart Disease in Korea

Affiliations
  • 1School of Medicine, Korea University, Seoul, Korea.
  • 2Department of Preventive Medicine, College of Medicine, Korea University, Seoul, Korea. yoonsj02@korea.ac.kr
  • 3Department of Public Health, Graduate School of Korea University, Seoul, Korea.
  • 4Department of Nursing, Cheju Halla College, Jeju, Korea.

Abstract

BACKGROUND AND OBJECTIVES
The incidence of inflammatory heart diseases is not yet as high as those of other cardiovascular diseases; however, inflammatory heart diseases do have relatively high mortality rate. Therefore, update information on the economic burden of inflammatory heart diseases are necessary in order to appropriate policy making on these diseases.
MATERIALS AND METHODS
This study used a number of resources to obtain data, national health insurance statistics, the Korean Health Panel, and the causes of death report by the Korean National Statistical Office. The total costs of inflammatory heart diseases were estimated as the sum of direct medical care costs, direct non-medical care and indirect costs.
RESULTS
The total direct cost of inflammatory heart disease was higher in Korean men than that of Korean women and cost due to inpatient was higher than that of outpatients cost. The costs to cover premature death were highest among all of the components used to determine the total costs for inflammatory heart disease, representing 66.3% of these costs in Korea.
CONCLUSION
Inflammatory heart disease has a relatively high mortality rate, and the costs that are associated with premature deaths consume the greatest proportion of the costs associated with this disease. In spite of some limitations of study, this could be a reliable evidence of economic burden of inflammatory heart disease.

Keyword

Inflammation; Cost of illness; Endocarditis

MeSH Terms

Cause of Death
Cost of Illness
Endocarditis
Female
Health Care Costs
Heart
Heart Diseases
Humans
Incidence
Inflammation
Inpatients
Korea
Male
Mortality, Premature
National Health Programs
Outpatients
Policy Making

Reference

1. Fairweather D, Rose NR. Inflammatory heart disease: a role for cytokines. Lupus. 2005. 14:646–651.
2. The global burden of disease: 2004 update [Internet]. World Health Organization. cited 2009 Feb 20. Geneva: World Health Organization;Available from: http://www.who.int/healthinfo/global_burden_disease/estimates_regional/en/index.html.
3. Hufnagel G, Pankuweit S, Richter A, Schönian U, Maisch B. The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID)-first epidemiological results. Herz. 2000. 25:279–285.
4. Dec GW. Cooper LT, editor. Introduction to clinical myocarditis. Myocarditis: from bench to bedside. 2003. New Jersey: Human Press;257–281.
5. Drory Y, Turetz Y, Hiss Y, et al. Sudden unexpected death in persons less than 40 years of age. Am J Cardiol. 1991. 68:1388–1392.
6. Blauwet LA, Cooper LT. Myocarditis. Prog Cardiovasc Dis. 2010. 52:274–288.
7. Jung YH, Ko SJ. Estimating socioeconomic costs of five major diseases. Public Finance Revi. 2004. 18:77–104.
8. Kim SY, Yoon SJ, Jo MW, Kim EJ, Kim HJ, Oh IH. Economic burden of allergic rhinitis in Korea. Am J Rhinol Allergy. 2010. 24:e110–e113.
9. Mathers CD, Vos T, Lopez AD, Salomon J, Ezzati M. National Burden of Disease Studies: a Practical Guide. 2001. 2nd ed. Geneva: World Health Organization.
10. National Health Insurance Corporation. National Health Insurance Statistical Yearbook. 2007. Seoul: National Health Insurance Corp;488–489.
11. Park BH, Lee TJ, Lim WY. Incidence and magnitude of out-of-pocket payment and factors influencing them in Industrial Accident Compensation Insurance. Korean J Health Policy Adm. 2010. 20:103–124.
12. Kim JH, Jung JC, Lee HY, Choi SJ, Lee JK. Results of survey on medical care cost by patient. Survey on the Benefit Coverage Rate of National Health Insurance in 2005. 2006. Seoul: National Health Insurance Corp;131–138.
13. Yoon SJ, Kim EJ, Kim HJ, Oh Ih, Seo HY. A study on measuring the economic burden of cardio-cerebrovasucular disease in Korea. 2011. Seoul: Korea Centers for Disease Control and Prevention.
14. Korea Institute for Health and Social Affairs and National Health Insurance Corporation. Korea Health Panel [Internet]. Cited 2011 Jan 4. Seoul: Korea Institute for Health and Social Affairs and National Health Insurance corporation;Available from: http://www.khp.re.kr.
15. Survey Report on Wage Structure in 2008. Ministry of Labor[Internet]. cited 2011 Jan 4. Ministry of Labor;Available from: http://www.laborstatmolab.go.kr.
16. National Statistical Office. The Cause of Death Statistics of 2008. 2009. Seoul:
17. Kim J, Hahm MI, Park EC, et al. Economic burden of cancer in South Korea for the year 2005. J Prev Med Public Health. 2009. 42:190–198.
18. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA. 2002. 287:1308–1320.
19. World Heart Federation: different heart diseases [Internet]. cited 2011 Jan 4. Geneva: World Heart Federation;Available from: http://www.worldheart.org.
20. Ariza MA, Vimalananda VG, Rosenzweig JL. The economic consequences of diabetes and cardiovascular disease in the United States. Rev Endocr Metab Disord. 2010. 11:1–10.
Full Text Links
  • KCJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr